About MYOME, INC.
MyOme is a company that provides genomic analysis for personalized healthcare through whole genome sequencing and bioinformatics, offering actionable insights for patients and providers. They focus on proactive health tests, diagnostic testing, and integrated polygenic risk scores.
Whole genome sequencing and bioinformatics analysisProactive health tests including Single-Gene Risk, Medication Response, and Integrated Polygenic Risk Score (iPRS)Diagnostic tests for rare diseases including genome, exome, and copy number analysisComprehensive genomic sequencing from a single sampleSeamless end-to-end support for clinics and providersData security with no sale of information without explicit consent
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to MYOME, INC. right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.